We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
It’s yet another holiday being spent in (partial) sequestration: Cinco de Mayo (Spanish for “the 5th of May”) traditionally celebrates an important military victory for Mexico in the 19th century. A popular misconception is that this is the same as Mexican Independence Day, but nevertheless in the U.S. often translates to a party (fiesta) celebrating Mexican culture. And with reopening beginning in certain states around the country, we may see levels of commercial activity reminiscent of this past St Patrick’s Day — a long 7 weeks ago.
We also see results from the March Trade Deficit this morning, with a headline of -$44.4 billion almost exactly in-line with analyst projections. This followed an unrevised -$39.9 billion from February, which was the lowest read since September of 2016, and much better than the multi-year low of -$61 billion we experienced in December of 2018.
That said, analysts are looking toward the possibility that domestic Imports and Exports may fall further out of line, toward a deepening of the trade deficit in future months, as methods for stopping the spread of coronavirus are seeing U.S. manufacturing in mothballs of late. Perhaps U.S. oil — up big this morning and much higher than we saw back when May contracts expired — can buffer our trade numbers going forward somewhat.
Regeneron (REGN - Free Report) , the pharmaceutical company that makes remdesivir, the treatment hopeful for patients suffering from COVID-19, posted big beats in its Q1 report this morning. Earnings of $6.60 per share was well ahead of the $5.73 per share expected, and +48.3% year over year. Revenues of $1.83 billion easily surpassed the $1.69 billion, swinging to year-over-year growth.
The company also announced an expanded agreement with U.S. Health & Human Services (HHS) regarding a remdesivir-based antibody “cocktail” treatment called REGN-COV2. Regeneron also has attained a partnership with Chinese pharmaceutical company Zai Labs (ZLAB - Free Report) with its REGN1979 treatment, a bi-specific antibody. The pricing of remdesivir-based products will be key for this stock in the medium-term, but the Zacks Rank #3 (Hold)-rated company has emerged as one of the important players in the coronavirus saga.
Zacks Rank #1 (Strong Buy)-rated Wayfair (W - Free Report) , and recent Zacks Bull of the Day selection, has rocketed up 30% in today’s pre-market after posting a better-than-expected quarterly loss of $2.30 per share, an improvement from the -$2.55 per share expected. Sales in the quarter came in at $2.33 billion — a smidge below the Zacks consensus. Wayfair stock is now up more than 75% year to date. For more on W’s earnings, click here.
After today’s closing bell, we get fresh earnings results from Disney (DIS - Free Report) , Electronic Arts (EA - Free Report) , Activision Blizzard , Beyond Meat (BYND - Free Report) and more. The heart of Q1 earnings season beats on. Have a happy and safe Cinco de Mayo!
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Q1 Earnings and Economic Data Deluge
It’s yet another holiday being spent in (partial) sequestration: Cinco de Mayo (Spanish for “the 5th of May”) traditionally celebrates an important military victory for Mexico in the 19th century. A popular misconception is that this is the same as Mexican Independence Day, but nevertheless in the U.S. often translates to a party (fiesta) celebrating Mexican culture. And with reopening beginning in certain states around the country, we may see levels of commercial activity reminiscent of this past St Patrick’s Day — a long 7 weeks ago.
We also see results from the March Trade Deficit this morning, with a headline of -$44.4 billion almost exactly in-line with analyst projections. This followed an unrevised -$39.9 billion from February, which was the lowest read since September of 2016, and much better than the multi-year low of -$61 billion we experienced in December of 2018.
That said, analysts are looking toward the possibility that domestic Imports and Exports may fall further out of line, toward a deepening of the trade deficit in future months, as methods for stopping the spread of coronavirus are seeing U.S. manufacturing in mothballs of late. Perhaps U.S. oil — up big this morning and much higher than we saw back when May contracts expired — can buffer our trade numbers going forward somewhat.
Regeneron (REGN - Free Report) , the pharmaceutical company that makes remdesivir, the treatment hopeful for patients suffering from COVID-19, posted big beats in its Q1 report this morning. Earnings of $6.60 per share was well ahead of the $5.73 per share expected, and +48.3% year over year. Revenues of $1.83 billion easily surpassed the $1.69 billion, swinging to year-over-year growth.
The company also announced an expanded agreement with U.S. Health & Human Services (HHS) regarding a remdesivir-based antibody “cocktail” treatment called REGN-COV2. Regeneron also has attained a partnership with Chinese pharmaceutical company Zai Labs (ZLAB - Free Report) with its REGN1979 treatment, a bi-specific antibody. The pricing of remdesivir-based products will be key for this stock in the medium-term, but the Zacks Rank #3 (Hold)-rated company has emerged as one of the important players in the coronavirus saga.
Zacks Rank #1 (Strong Buy)-rated Wayfair (W - Free Report) , and recent Zacks Bull of the Day selection, has rocketed up 30% in today’s pre-market after posting a better-than-expected quarterly loss of $2.30 per share, an improvement from the -$2.55 per share expected. Sales in the quarter came in at $2.33 billion — a smidge below the Zacks consensus. Wayfair stock is now up more than 75% year to date. For more on W’s earnings, click here.
After today’s closing bell, we get fresh earnings results from Disney (DIS - Free Report) , Electronic Arts (EA - Free Report) , Activision Blizzard , Beyond Meat (BYND - Free Report) and more. The heart of Q1 earnings season beats on. Have a happy and safe Cinco de Mayo!